<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"CTC":1,
"circulating biomarkers":1,
"miRNA":2,
"neuroendocrine tumors":2,
"prognosis":8,
"Assistive Device":1,
"Cancer Care":1,
"Falls":1,
"Fatigue":1,
"Patient Safety":1,
"Risk Management":1,
"Cancer":7,
"Couples":1,
"Differentiated thyroid cancer":8,
"Oncology":2,
"Quality of life":3,
"gastric cancer":2,
"metastasis":8,
"quercetin":1,
"uPA receptor":1,
"urokinase plasminogen activator":1,
"Case report":1,
"Epiphyseal displacement of humerus":1,
"Genu valgum":1,
"Primary hyperparathyroidism":2,
"Pubertal growth spurt":1,
"Slipped upper femoral epiphysis":1,
"Lenvatinib":4,
"Squamous cell carcinoma":3,
"Thyroid":16,
"Fatal thyroid cancer":1,
"Genetics":1,
"MET":1,
"MLH1":1,
"PDGFRA":1,
"Inadvertent parathyroidectomy":1,
"Incidental parathyroidectomy":1,
"Aspiration technique":1,
"Capillary action":1,
"FNA":2,
"Fine needle aspiration":2,
"Non diagnostic rates":1,
"Thyroid nodule":7,
"Papillary thyroid carcinoma":16,
"Surgical instruments":1,
"Thyroidectomy":7,
"Voice":1,
"Amyloid":1,
"Amyloid goiter":1,
"Frozen section":2,
"Medullary thyroid carcinoma":5,
"Parathyroid":2,
"outcome":2,
"pregnancy":3,
"treatment":4,
"Bethesda III":1,
"Bethesda IV":1,
"Thyroid cancer":21,
"follicular neoplasm":1,
"Anti-thyroglobulin antibodies":1,
"Thyroglobulin":3,
"Thyroid carcinoma":7,
"false negative":1,
"false positive":1,
"size":1,
"thyroid nodules":8,
"thyroid/parathyroid":2,
"ultrasound features":1,
"ultrasound-guided fine-needle aspiration":1,
"Dipeptidyl peptidase-IV inhibitor":1,
"Gemigliptin":1,
"PXD101":1,
"Synergism":1,
"Hürthle cell":1,
"follicular thyroid carcinoma":1,
"neoplasm metastasis":2,
"cystic thyroid nodule":1,
"ethanol injection":2,
"polidocanol injection":1,
"therapeutic":1,
"ultrasound":4,
"Foxp3":1,
"Thyroiditis":1,
"Cancer immunotherapy":2,
"Endocrine adverse events":1,
"Immune checkpoint inhibitors":1,
"Thyroid dysfunctions":1,
"Meta-analysis":5,
"Risk assessment":1,
"Thyroid neoplasm":3,
"Ultrasonography":6,
"Anti-mullerian hormone":1,
"Radioactive iodine":3,
"Active surveillance":2,
"Patient age":1,
"Thyroid surgery":2,
"Calcinosis":1,
"Diagnosis":4,
"Neoplasms":3,
"Thyroid gland":1,
"Ablation techniques":2,
"High-intensity focused ultrasound ablation":2,
"Induced hyperthermia":1,
"Interventional ultrasonography":2,
"Nodular goitre":2,
"Pain management":1,
"Angiosarcoma":1,
"Dedifferentiated liposarcoma":1,
"Epithelioid sarcoma":1,
"Ewing sarcoma":1,
"Immunohistochemistry":5,
"Neuroblastoma":1,
"PEComa":1,
"Sarcoma":1,
"Synovial sarcoma":1,
"ERα36":1,
"GRP78":1,
"GRP94":1,
"Papillary thyroid cancer":5,
"Adenolipoma":2,
"encapsulated":1,
"follicular":2,
"infiltrative":1,
"invasive":1,
"CNXI":1,
"arrest":1,
"baroreceptor":1,
"cardiac":1,
"etiology":1,
"intraoperative":1,
"otolaryngology":1,
"spinal accessory nerve":1,
"surgery":6,
"trigeminocardiac reflex":1,
"vagal":1,
"vagus":1,
"Lymph node dissection":1,
"Papillary carcinoma":1,
"Pediatric":1,
"Radiation":1,
"carcinoma":1,
"hemithyroidectomy":1,
"pathology":3,
"S100A8/A9":1,
"esophageal squamous cell carcinoma":1,
"nasopharyngeal squamous cell carcinoma":1,
"oral squamous cell carcinoma":1,
"oropharyngeal squamous cell carcinoma":1,
"thyroid adenocarcinoma":1,
"hypercalcemia":1,
"hyperparathyroidism":1,
"lytic bone lesions":1,
"FRACTURE":1,
"HEALTH SERVICES RESEARCH":1,
"OSTEOPOROSIS":1,
"Adenosine":1,
"CD73":1,
"Extracellular ATP":1,
"NTPDases":1,
"Purinergic signaling":1,
"Thyroid papillary carcinoma":2,
"thyroid cancer survivor":1,
"Kelch-ECH-associating protein-1 (KEAP1)":1,
"NRF2":1,
"antioxidant":1,
"mutation":2,
"Calcium signaling":1,
"Dose-response":1,
"Gene expression":1,
"Harderian gland":1,
"Human health risk assessment":1,
"Lung":1,
"Mode of action":1,
"anaplastic thyroid cancer":3,
"lovastatin":2,
"oxythiamine":1,
"proliferation":3,
"transketolase (TKT)":1,
"Breast cancer":8,
"Second primary cancer":1,
"Tumor staging":1,
"DNA methylation":1,
"aging":1,
"chromatin":1,
"epigenetics":1,
"histone modification":1,
"ATC":1,
"Anaplastic thyroid carcinoma":2,
"TGF-α":1,
"cisplatin sensitivity":1,
"in vitro":1,
"in vivo":1,
"miR-144":1,
"cytology":7,
"metastatic":1,
"thyroid peroxidase":1,
"follicular adenoma":2,
"follicular carcinoma":3,
"growth kinetics":1,
"tumour growth":1,
"Airborne polychlorinated biphenyls":1,
"Endocrine disruption":1,
"HydroxyLated PCBs":1,
"Metabolism of xenobiotics":1,
"Tumor promotion":1,
"Bethesda category IV nodules":1,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"risk factors for carcinoma":1,
"Central node dissection":1,
"Lymph node metastases":1,
"Morbidity":1,
"Neuromonitoring":1,
"Recurrent laryngeal nerve":1,
"Melatonin":1,
"Radioresistance":2,
"Reactive oxygen species":1,
"p65":1,
"Bone":2,
"Pattern of metastasis":1,
"Skeletal":1,
"Hepatocyte growth factor":1,
"Invasion":1,
"Serine protease inhibitor":1,
"Lymphocyte to monocyte ratio":1,
"Pancreatic cancer":1,
"Developed world":1,
"Developing world":1,
"Iodine deficiency":1,
"Low-resource setting":1,
"Thyroid disease":4,
"Biomarker":1,
"DCLK1":1,
"miR-424":1,
"microRNA":1,
"Risk factor":2,
"SEER":1,
"Second primary female genital cancer":1,
"Astrocyte elevated gene 1":1,
"Cell proliferation":3,
"MicroRNA-625-3p":1,
"Wnt/β-catenin":1,
"c-Jun N-terminal kinase pathway":1,
"PET/CT":2,
"anti-thyroglobulin antibody":1,
"positron emission tomography":1,
"TNM":1,
"comparison":1,
"staging systems":1,
"Artifacts":1,
"Elastography":1,
"FNA biopsy":1,
"cytopathology":1,
"ectopic thymus":1,
"paediatric patients":1,
"BRAF":1,
"V600E":1,
"biomarkers":3,
"cell blocks":1,
"fine-needle aspiration":4,
"immunoperoxidase stain":1,
"immunostaining":1,
"molecular":1,
"smears":1,
"American Thyroid Association (ATA)":1,
"fine-needle aspiration (FNA)":2,
"medullary thyroid carcinoma (MTC)":1,
"multiple endocrine neoplasia (MEN) syndrome":1,
"pitfalls":1,
"Aziridonin":1,
"NRF-2/RHOA/ROCK pathway":1,
"Oridonin":1,
"YD0514":1,
"F-18 FDG PET/CT":1,
"visceral fat":1,
"Bethesda":1,
"Citología":1,
"Cáncer de tiroides":1,
"Punción-aspiración con aguja fina":1,
"RAS":1,
"RET":1,
"genetic alteration":1,
"hereditary":1,
"recurrence":1,
"relapse":1,
"review":1,
"sporadic":1,
"survival":2,
"BRAFV600E":2,
"PET":2,
"TERT promoter mutation":1,
"apatinib":1,
"integrin receptor avβ3 imaging":1,
"radioactive iodine-refractory thyroid cancer":1,
"response assessment":1,
"Diagnostic criteria":1,
"Poorly differentiated carcinoma":1,
"Advanced gastric cancer":1,
"Combination chemotherapy":1,
"Oxaliplatin":1,
"Paclitaxel":1,
"Differentially expressed genes":2,
"Gene expression omnibus":1,
"Microarray analysis":1,
"Adenocarcinoma, follicular":1,
"Carcinoma, papillary":3,
"NIFTP":2,
"Thyroid neoplasm/diagnosis":1,
"Thyroid neoplasm/genetics":1,
"Atypical parathyroid adenoma":1,
"Parafibromin":1,
"Parathyroid carcinoma":2,
"Parathyroid hormone":1,
"Asia":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"follicular variant of papillary thyroid carcinoma":1,
"risk of malignancy (ROM)":1,
"the Bethesda system for reporting thyroid cytopathology":1,
"calcitonin":2,
"procalcitonin":2,
"PI3K/Akt signaling pathway":1,
"breast neoplasm":1,
"doxorubicin":1,
"resveratrol":1,
"follicular variant of papillary thyroid carcinoma, NIFTP":1,
"papillary thyroid carcinoma with predominant follicular pattern":1,
"Flushing":1,
"Gastrointestinal":1,
"Neuroendocrine Tumor":1,
"Systemic Mastocytosis":1,
"human":2,
"efficacy":1,
"exploratory analysis":1,
"treatment-emergent hypertension":1,
"RET proto-oncogene":1,
"age-related progression":1,
"germline mutation":1,
"lymph node metastasis":1,
"translational medicine":1,
"cancer genome/genetics":1,
"characteristics and pathology of human cancer":1,
"information":1,
"invasion and metastasis":1,
"oncogenes and tumor-suppressor genes":1,
"Physician perceptions":1,
"RAS mutation":1,
"fine-needle aspirate":1,
"cervical ultrasound":1,
"diagnostic accuracy":1,
"follow-up":1,
"EIF1AX":1,
"HRAS":1,
"TERT":1,
"hormone receptor":1,
"postmenopausal":1,
"premenopausal":1,
"Cabozantinib":1,
"Cancer types":1,
"Population pharmacokinetics":1,
"Focal nodular hyperplasia":1,
"Hemangioma":1,
"Liver cysts":1,
"Washout":1,
"Survey":1,
"Key words":1,
"ROCK1":1,
"miR-361-5p":1,
"SRC-1":1,
"VEGFC":1,
"lymphatic metastases":1,
"Central lymph node":1,
"Clinicopathological factors":1,
"Connexin 31":1,
"Ginsenoside":1,
"SELECT":1,
"duration of response":1,
"radioiodine-refractory differentiated thyroid carcinoma":1,
"incidentaloma":2,
"ultrasound imaging":1,
"Denmark":1,
"hereditary medullary thyroid carcinoma":1,
"incidence":3,
"prevalence":1,
"sporadic medullary thyroid carcinoma":1,
"Organ at risk":1,
"Radiotherapy":3,
"Thyroid dysfunction":1,
"Remnant ablation":1,
"Star artifact":1,
"Therapeutic uses":1,
"Thyroid neoplasms":6,
"LMO7–BRAF":1,
"fusion gene":1,
"Hypothyroidism":1,
"Levothyroxine":1,
"Malabsorption":1,
"Neurologic manifestations":1,
"electronic health records":1,
"genetic variation":1,
"genome-wide association study":3,
"hospitals":1,
"humans":1,
"multifactorial inheritance":1,
"phenome-wide association study":1,
"phenotype":1,
"risk":1,
"MAPK signaling pathway":1,
"apoptosis":2,
"cell-cycle arrest":1,
"diallyl trisulfide":1,
"bioinformatics":1,
"depression":1,
"traditional Chinese medicine":1,
"uterine fibroids":1,
"sphingosine kinase 1":1,
"sphingosine-1-phosphate":1,
"sphingosine-1-phosphate receptor 3":1,
"K1 cells":1,
"chaperonin containing TCP1 subunit 3":1,
"B-Raf proto-oncogene serine/threonine kinaseV600E":1,
"MpS1":1,
"phospho-mitogen-activated protein kinases":1,
"differenciált pajzsmirigy-carcinoma":1,
"follicularis":1,
"pajzsmirigy":1,
"papillaris":1,
"papillary":1,
"radioiodine treatment":1,
"radiojód":1,
"HMGB1":1,
"Hepatocellular carcinoma":1,
"RAGE":1,
"hepatic resection":1,
"tumor differentiation":1,
"AKT":1,
"PDZ-LIM family":1,
"enigma":1,
"survivin":1,
"Teratoma of the ovary":1,
"papillary renal cell cancer":1,
"struma ovarii":1,
"X-ray computed tomography":1,
"Cisplatin":1,
"Combination strategies":1,
"Glycolytic pathway":1,
"Inhibitors":1,
"Metformin":1,
"Ovarian cancer":1,
"Endocrine disruptor":1,
"Environmental exposures":1,
"Flame retardants":1,
"Women’s health":1,
"Fe3O4 superparticles":1,
"anti-metastasis":1,
"checkpoint blockade therapy":1,
"photothermal-activatable":1,
"endocrine cancer":3,
"immunology":1,
"urological cancer":1,
"EBER ISH":1,
"Epstein-Barr virus":1,
"Lymphoepithelioma-like carcinoma":1,
"Autoimmune gastritis":1,
"Biliary tract cancer":1,
"Cancer risk":1,
"Leukaemia":1,
"Lymphoma":2,
"Pernicious anaemia":1,
"Systematic review":1,
"Iodine radioisotopes":2,
"bone marrow thyroid neoplasms":1,
"18F-FDG PET/CT Hurthle cell adenoma":1,
"head and neck surgery":1,
"screening (oncology)":1,
"DNAJC8":1,
"HSP40":1,
"glucose transporter":1,
"glycolysis":1,
"pyruvate kinase M2":1,
"tazarotene-induced gene 1":1,
"Surgical flaps":1,
"Tracheal defect":1,
"Clinicopathological predictors":1,
"Disease free survival":1,
"Hypoxia inducible factor-1α":1,
"Overall survival":1,
"Prolyl 4-hydroxylase beta polypeptide":1,
"autoimmun thyreoiditis":1,
"autoimmune thyroiditis":1,
"papillaris pajzsmirigy-carcinoma":1,
"thyreoidectomia":1,
"thyreolipoma":1,
"thyrolipoma":1,
"Classification":1,
"Feature extraction":1,
"TIRADS ultrasound":1,
"Hashimoto’s disease":1,
"Immune checkpoint inhibitor":1,
"Thyroid storm":1,
"Carbon nanoparticle suspension":1,
"Sentinel lymph node biopsy":1,
"dermatology":1,
"breast surgery":1,
"anterior commissure":1,
"laryngeal neoplasms":2,
"lasers":1,
"radiofrequency coblation":1,
"Castleman disease":1,
"head and neck":1,
"fine needle aspiration cytology":2,
"fine needle nonaspiration cytology":1,
"laryngostenosis":1,
"surgical procedures,operative":1,
"TAAs":1,
"autoantibody":1,
"survivin lung cancer":1,
"Neck dissection":1,
"Risk factors":1,
"Surgical procedures, operative":1,
"eighth edition of the Union for International Cancer Control TNM Classification of Malignant Tumors":1,
"lymph node density":1,
"multivariate":1,
"CXCR4":1,
"breast carcinoma":1,
"chemokine receptors":1,
"chemokines":1,
"myeloma":1,
"prostate carcinoma":1,
"cervical lymph node":1,
"clinical target volume":1,
"intensity-modulated radiation therapy":1,
"nasopharyngeal carcinoma":1,
"HMGCR":1,
"PPARγ":1,
"RB":1,
"p21cip":1,
"p27cip":1,
"troglitazone":1,
"Kerman":1,
"Clinical characteristics":1,
"Lung neoplasms":1,
"Pulmonary mucoepidermoid carcinoma":1,
"Brown tumor":1,
"Giant cell tumor":1,
"Body mass index":1,
"Central lymph node metastasis":1,
"Papillary thyroid microcarcinoma":2,
"EMC":1,
"KIT":1,
"extraskeletal myxoid chondrosarcoma":1,
"next generation sequencing":1,
"Genetic loci":1,
"Genetic predisposition to disease":1,
"Genetic testing":1,
"Polymorphism, single nucleotide":1,
"Graves disease":1,
"Hashimoto disease":1,
"Thyroid function":1,
"Low-risk":1,
"Micropapillary":1,
"Thyroid cancer, medullary":1,
"Multimodal treatment":1,
"Tracheal perforation":1,
"Tyrosine kinase inhibitor":2,
"5 mm":1,
"clinicopathological":1,
"ultrasonographic":1,
"Cervical mass":1,
"microcarcinoma":1,
"occult thyroid cancer":1,
"Gynecologic cancers":1,
"axillary lymph node":1,
"maximum standardized uptake value":1,
"metachronous":1,
"positron emission tomography/computed tomography":1,
"cytology diagnostic certainty":1,
"endocrine":1,
"endocrine neoplasms":2,
"organ system pathology":2,
"pathology competencies":2,
"clinical features":1,
"cytologic diagnosis":1,
"molecular basis":1,
"pathologic features":1,
"Intensity-modulated radiotherapy":1,
"Progression-free survival":1,
"Highly sensitive thyroglobulin assay":1,
"Neck ultrasound":1,
"TSH-stimulated thyroglobulin test":1,
"C–C motif":1,
"HER2−":1,
"chemokine":1,
"collagen IV":1,
"ligand 5":1,
"luminal B":1,
"quantum dot":1,
"color doppler":1,
"TIRADS":1,
"Acute pancreatitis":1,
"Differentiated thyroid carcinoma":1,
"Iodine-refractory thyroid cancer":1,
"Sorafenib":1,
"Oncological evaluation":1,
"Radioiodine ablation":1,
"Radioiodine therapy":1,
"Robotic surgery":1,
"ARPP19":1,
"miR-26a":1,
"tamoxifen":1,
"Lung cancer":2,
"computed tomography (CT)":1,
"incidental findings (IFs)":1,
"low-dose computed tomography (LDCT)":1,
"neoplasm":1,
"screening":1,
"Autopsy":1,
"PAX8":1,
"Paired box 8":1,
"humerus fracture":1,
"superior sagittal sinus invasion":1,
"juvenile goiter":1,
"Adrenal Gland Neoplasms":1,
"Single Photon Emission Computed Tomography Computed Tomography":1,
"FoxA1":1,
"FoxA2":1,
"NKX2-1":1,
"cancer biology":1,
"lineage switching":1,
"mouse":1,
"Carcinoma, Neuroendocrine":1,
"Neoplasms, Unknown Primary":1,
"Endotoxin":1,
"Farming":1,
"Pesticides":1,
"fine‐needle aspiration":1,
"multinodular goitre":1,
"Bacterial infections":1,
"Rodentia":1,
"parasitic diseases":1,
"trauma":1,
"long noncoding RNA H19":1,
"long noncoding RNA PTCSC3":1,
"triple-negative breast cancer":1,
"hashimoto thyroiditis":1,
"press and release method":1,
"smearing technique":1,
"Autoantibodies":1,
"chronic lymphocytic thyroiditis":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2018年6月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
